Heartflow PCI Navigator entered commercial use outside of clinical trials, with The Valley Hospital becoming the first U.S. institution to deploy the software. The AI-powered tool provides interventional cardiologists with a personalized 3D model detailing vessel sizing, plaque buildup, and blood flow to plan coronary angioplasty and stent placement before entering the catheterization lab.
Our readThis marks the commercial availability of Heartflow's percutaneous coronary intervention planning capability, expanding the platform's utility from non-invasive diagnostics into interventional cardiology. Buyers can now evaluate this tool to gain pre-procedural insights, allowing clinical teams to establish treatment strategies and select device sizes before the procedure begins.